Patrick T. Grogan

2.0k total citations
33 papers, 1.4k citations indexed

About

Patrick T. Grogan is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Patrick T. Grogan has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Patrick T. Grogan's work include Glioma Diagnosis and Treatment (11 papers), Phytochemicals and Medicinal Plants (9 papers) and Medicinal Plants and Neuroprotection (4 papers). Patrick T. Grogan is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Phytochemicals and Medicinal Plants (9 papers) and Medicinal Plants and Neuroprotection (4 papers). Patrick T. Grogan collaborates with scholars based in United States, United Kingdom and Switzerland. Patrick T. Grogan's co-authors include Jann N. Sarkaria, Brett L. Carlson, Mark A. Schroeder, Gaspar J. Kitange, C. David James, Wenting Wu, Paul A. Decker, Caterina Giannini, Mark S. Cohen and Barbara N. Timmermann and has published in prestigious journals such as Cancer, Cancer Research and Clinical Cancer Research.

In The Last Decade

Patrick T. Grogan

31 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick T. Grogan United States 18 740 604 361 309 193 33 1.4k
Jill Wykosky United States 13 904 1.2× 340 0.6× 397 1.1× 304 1.0× 117 0.6× 25 1.7k
Steffen C. Naumann Germany 11 1.1k 1.5× 434 0.7× 388 1.1× 370 1.2× 134 0.7× 13 1.5k
Xuguang Zheng United States 19 1.2k 1.6× 178 0.3× 262 0.7× 903 2.9× 121 0.6× 32 1.8k
Nichola Cruickshanks United States 22 1.0k 1.4× 285 0.5× 309 0.9× 236 0.8× 111 0.6× 34 1.6k
Yanyang Tu China 26 1.2k 1.7× 248 0.4× 288 0.8× 749 2.4× 130 0.7× 71 1.7k
Deepa Sampath United States 26 1.5k 2.0× 318 0.5× 608 1.7× 452 1.5× 84 0.4× 68 2.2k
Monica Gatti Italy 20 561 0.8× 194 0.3× 467 1.3× 217 0.7× 130 0.7× 26 1.1k

Countries citing papers authored by Patrick T. Grogan

Since Specialization
Citations

This map shows the geographic impact of Patrick T. Grogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick T. Grogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick T. Grogan more than expected).

Fields of papers citing papers by Patrick T. Grogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick T. Grogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick T. Grogan. The network helps show where Patrick T. Grogan may publish in the future.

Co-authorship network of co-authors of Patrick T. Grogan

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick T. Grogan. A scholar is included among the top collaborators of Patrick T. Grogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick T. Grogan. Patrick T. Grogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Padmanabhan, Jaya, Patrick T. Grogan, Derek R. Duckett, et al.. (2025). STEM-16. COMBINATION THERAPIES WITH CDK9 INHIBITORS AS A PROMISING STRATEGY TO OVERCOME THERAPY RESISTANCE IN GLIOBLASTOMAS. Neuro-Oncology. 27(Supplement_5). v81–v81.
2.
Grogan, Patrick T., Jeffrey Helgager, Dustin A. Deming, et al.. (2023). Case report: Radiographic complete response of radiation-induced glioblastoma to front-line radiotherapy: A report and molecular characterization of two unique cases. Frontiers in Neurology. 14. 1099424–1099424. 2 indexed citations
3.
DeStefanis, Rebecca A., Philip B. Emmerich, Patrick T. Grogan, et al.. (2020). Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection. Current Treatment Options in Oncology. 21(5). 35–35. 7 indexed citations
5.
Subramanian, Chitra, Patrick T. Grogan, Ton Wang, et al.. (2020). Novel C‐terminal heat shock protein 90 inhibitors target breast cancer stem cells and block migration, self‐renewal, and epithelial–mesenchymal transition. Molecular Oncology. 14(9). 2058–2068. 14 indexed citations
6.
Sim, Michael W., Patrick T. Grogan, Chitra Subramanian, et al.. (2015). Effects of peritumoral nanoconjugated cisplatin on laryngeal cancer stem cells. The Laryngoscope. 126(5). E184–90. 14 indexed citations
7.
Grogan, Patrick T., Jann N. Sarkaria, Barbara N. Timmermann, & Mark S. Cohen. (2014). Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation. Investigational New Drugs. 32(4). 604–617. 63 indexed citations
8.
Cen, Ling, Brett L. Carlson, Jenny L. Pokorny, et al.. (2013). Efficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft models. Neuro-Oncology. 15(6). 735–746. 24 indexed citations
9.
Cohen, Mark S., et al.. (2012). In Vitro and In Vivo Cytotoxic Effects of Withaferin A on Retinal Epithelial Pigmented Cells. Investigative Ophthalmology & Visual Science. 53(14). 5364–5364. 1 indexed citations
11.
Shrivastav, Meena, et al.. (2012). ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells. Journal of Neuro-Oncology. 110(3). 349–357. 52 indexed citations
12.
Olin, Michael R., Brian M. Andersen, Adam J. Litterman, et al.. (2011). Oxygen Is a Master Regulator of the Immunogenicity of Primary Human Glioma Cells. Cancer Research. 71(21). 6583–6589. 17 indexed citations
13.
Pluhar, G. Elizabeth, Patrick T. Grogan, Michelle R. Goulart, et al.. (2010). Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapy. Vaccine. 28(19). 3371–3378. 38 indexed citations
14.
Carlson, Brett L., Patrick T. Grogan, Ann C. Mladek, et al.. (2009). Radiosensitizing Effects of Temozolomide Observed in vivo only in a Subset of O6-Methylguanine-DNA Methyltransferase Methylated Glioblastoma Multiforme Xenografts. International Journal of Radiation Oncology*Biology*Physics. 75(1). 212–219. 75 indexed citations
15.
Clarke, Michelle J., Evan A. Mulligan, Patrick T. Grogan, et al.. (2009). Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines. Molecular Cancer Therapeutics. 8(2). 407–414. 77 indexed citations
16.
Kitange, Gaspar J., Brett L. Carlson, Mark A. Schroeder, et al.. (2008). Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts. Neuro-Oncology. 11(3). 281–291. 297 indexed citations
17.
Kitange, Gaspar J., Brett L. Carlson, Ann C. Mladek, et al.. (2008). Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model. Journal of Neuro-Oncology. 92(1). 23–31. 74 indexed citations
18.
Clarke, Michelle J., Mark A. Schroeder, Brett L. Carlson, et al.. (2008). Development of Resistance in Multicycle Temozolomide Chemotherapy for Glioblastomas. Neurosurgery. 62(6). 1425–1426. 1 indexed citations
19.
Sarkaria, Jann N., Steven E. Schild, Patrick T. Grogan, et al.. (2007). Phase I Trial of Sirolimus Combined with Radiation and Cisplatin in Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 2(8). 751–757. 39 indexed citations
20.
Sarkaria, Jann N., Lin Yang, Patrick T. Grogan, et al.. (2007). Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel. Molecular Cancer Therapeutics. 6(3). 1167–1174. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026